Foreign For Profit

TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevate

Flow Regulation by Opening the Septum in Patients with Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

A Phase I, Dose Escalation Safety and Tolerability Study of VAXINIA (CF33-hNIS), Administered Intratumorally or Intravenously as a Monotherapy or in Combination with Pembrolizumab in Adult Patients wi

A Phase I Clinical Trial to Evaluate the Safety and Tolerability of VLP Peanut in Healthy Subjects and Subjects With Peanut Allergy and to Explore Preliminary Signals of Its Efficacy (PROTECT)

Evaluation of Yokogawas RAPID technology for allocation of log reduction levels of viruses in water using a novel engineering-scale ultrafiltration system.

Algorithms for 3-D Birefringence from Tomographic Polarimetry

A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous P

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreate

Investigation of the role of neuronal and dural mast cell PAR-2 activation in episodic and chronic migraine using a novel, translatable injury-free preclinical model - supplemental time and funds